middle.news
Alcidion Secures $13.1M in Q2 Sales, Eyes EBITDA Positivity in FY25
8:22am on Thursday 30th of January, 2025 AEDT
•
Healthcare Technology
Read Story
Alcidion Secures $13.1M in Q2 Sales, Eyes EBITDA Positivity in FY25
8:22am on Thursday 30th of January, 2025 AEDT
Key Points
Q2 new sales total $13.1 million with $4.5 million revenue expected in FY25
Operating cash outflow improved to $0.26 million, a $3.1 million gain over Q2 FY24
Contracted revenue at $30.8 million excluding pending North Cumbria deal
Cash balance stands at $7.7 million with zero debt
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Alcidion (ASX:ALC)
OPEN ARTICLE